title: Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report.
abstract: A very-low-birth-weight infant died from pericardial effusion and cardiac tamponade confirmed by the post-mortem findings. The mother suffered from lupus-like syndrome consequent to hydralazine treatment for pregnancy-induced hypertension. The possible relationship between mother-infant pathology and hydralazine administration is discussed.
authors.affiliation: Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Yemini
authors.forename: Z
authors.initials: Z
authors.lastname: Shoham
authors.forename: R
authors.initials: R
authors.lastname: Dgani
authors.forename: M
authors.initials: M
authors.lastname: Lancet
authors.forename: B M
authors.initials: BM
authors.lastname: Mogilner
authors.forename: F
authors.initials: F
authors.lastname: Nissim
authors.forename: Y
authors.initials: Y
authors.lastname: Bar-Khayim
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007231:Infant, Newborn; D008177:Lupus Vulgaris / Q000139:chemically induced*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects; D013577:Syndrome
chemical_list: D006830:Hydralazine